Cover image of the article: Side Effects of Sustained-Release Vaginal Suppository Progesterone in Pregnant Women: Gestational Diabetes Mellitus

Image Credit:Ann Mil Health Sci Res

Side Effects of Sustained-Release Vaginal Suppository Progesterone in Pregnant Women: Gestational Diabetes Mellitus

Authors

Neda Kheyri1, Maryam Anbarlooi1, soraya saleh gargari2,*, Fatemeh Sadat Sarfjoo3
1Researcher, Department of obstetrics and gynecology, Mahdiyeh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Andorra
2Department of obstetrics and gynecology, Mahdiyeh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Andorra
3- Researcher, Department of obstetrics and gynecology, Mahdiyeh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Andorra
*Corresponding Author: Corresponding author: soraya saleh gargari, Department of obstetrics and gynecology, Mahdiyeh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Andorra Email: soraya_saleh2000@yahoo.co.uk

Annals of Military and Health Sciences Research:Vol. 11, issue 4; e64614
Published online:Dec 02, 2013
Article type:Research Article
Received:Aug 24, 2013
Accepted:Nov 17, 2013
How to Cite:Kheyri N, Anbarlooi M, saleh gargari S, Sarfjoo FS. Side Effects of Sustained-Release Vaginal Suppository Progesterone in Pregnant Women: Gestational Diabetes Mellitus. Ann Mil Health Sci Res. 2013;11(4):e64614. doi:

Abstract

Background: Evaluation of the potential impact of vaginal progesterone on both mother and fetus is necessary before expanding the indication of this drug especially throughout pregnancy. To evaluate the potential impact of vaginal progesterone on both mother and fetus. Materials and Methods: This case-control study was designed to collect data on the potential gestational diabetes mellitus complication associated with progesterone use comparing maternal and neonatal outcomes between 245pregnant women receiving vaginal suppository of Cyclogest (200mg) and 808controls without progesterone. Results: The incidence of gestational diabetes was 9.8% and 5.2% in case and control groups, respectively (p=0.039). According to linear regression analysis, there was a direct association between duration of progesterone usage and impairment of glucose tolerance test in group of cases (r=0.43; p=0.002). Conclusions: The use of progesterone for the prevention of recurrent preterm delivery could associate with an increased risk of developing gestational diabetes.

Highlights

Fulltext

full text is available in pdf.

References

  • 1.
    References are available in pdf.

Copyright

© 2013, Annals of Military and Health Sciences Research. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

11
Nov
2023
Micronized Progesterone or Dydrogesterone? A Comparative Study on the Effects of Two Forms of Progesterone on Pregnancy Outcomes After Threatened Abortion

Micronized Progesterone or Dydrogesterone? A Comparative Study on the Effects of Two Forms of Progesterone on Pregnancy Outcomes After Threatened Abortion

Iman Ansari,
Ezzatalsadat Hajiseid Javadi,
Hamideh Pakniat,
Ali Emami,
Fatemeh Ranjkesh,
Simindokht Molaverdikhani

Ansari I, Hajiseid Javadi E, Pakniat H, Emami A, Ranjkesh F, et al. Micronized Progesterone or Dydrogesterone? A Comparative Study on the Effects of Two Forms of Progesterone on Pregnancy Outcomes After Threatened Abortion. Iran J Pharm Res. 2023;22(1):e136320. doi: https://doi.org/10.5812/ijpr-136320

30
Dec
2023
Comparative Analysis of Corticosteroid Therapy in Pregnant Women with COVID-19: Evaluating Glycemic Control and Transient Hyperglycemia

Comparative Analysis of Corticosteroid Therapy in Pregnant Women with COVID-19: Evaluating Glycemic Control and Transient Hyperglycemia

Mohammad Reza Salehi,
Marjan Ghaemi,
Sahar Masoumi,
Sina Azadnajafabad,
Amir Hossein Norooznezhad,
Fahimeh Ghotbizadeh Vahdani
,et al.

Salehi MR, Ghaemi M, Masoumi S, Azadnajafabad S, Norooznezhad AH, et al. Comparative Analysis of Corticosteroid Therapy in Pregnant Women with COVID-19: Evaluating Glycemic Control and Transient Hyperglycemia. Fertil Gynecol Androl. 2023;3(1):e142142. doi: https://doi.org/10.5812/fga-142142

20
Jun
2022
Comparison of Pregnancy Outcomes in Diabetic and Healthy Women

Comparison of Pregnancy Outcomes in Diabetic and Healthy Women

Mostafa Jafari,
Hadis Fattahi,
Leila Sheikhy,
Sodabeh Eskandari,
Mehdi Mirzaei-Alavijeh

Jafari M, Fattahi H, Sheikhy L, Eskandari S, Mirzaei-Alavijeh M. Comparison of Pregnancy Outcomes in Diabetic and Healthy Women. J Health Rep Technol. 2022;8(3):e119317. doi: https://doi.org/10.5812/jhrt-119317

31
Jul
2007
Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus

Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus

MU Farooq,
A Ayaz,
L Ali Bahoo,
I Ahmad

Farooq M, Ayaz A, Ali Bahoo L, Ahmad I. Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus. Int J Endocrinol Metab. 2007;5(3):. doi:

2
Sep
2025
The Effect of Vaginal Progesterone in Reducing Preterm Birth in Women with an Increased Uterocervical Angle: A Randomized Controlled Trial

The Effect of Vaginal Progesterone in Reducing Preterm Birth in Women with an Increased Uterocervical Angle: A Randomized Controlled Trial

Sedighe Borna,
Nasim Eshraghi,
Sedigheh Hantoushzadeh,
Fahimeh Ghotbizadeh Vahdani,
Zahra Panahi,
Kyana Jafarabady
,et al.

Borna S, Eshraghi N, Hantoushzadeh S, Ghotbizadeh Vahdani F, Panahi Z, et al. The Effect of Vaginal Progesterone in Reducing Preterm Birth in Women with an Increased Uterocervical Angle: A Randomized Controlled Trial. J Nurs Midwifery Sci. 2025;12(4):e160082. doi: https://doi.org/10.5812/jnms-160082

More by these authors

Neda KheyriPubMedScholar
Maryam AnbarlooiPubMedScholar
soraya saleh gargariPubMedScholar
Fatemeh Sadat SarfjooPubMedScholar
Share
Cited by
Metrics